Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | VP, Chf. Comp. & Quality Offc. | June 02, 2026 | June 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date June 02, 2026 · Filed June 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 5,656 |
Last balance in matching sequence
After 2026-06-02 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-06-02 · Grant · Acquired 1,155 · Balance 5,985 F1: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. Row 2 · 2026-06-02 · Tax withholding · Disposed 329 · Balance 5,656 F2: 329 shares were withheld from the 1,128 restricted shares that vested on June 2, 2026. These 329 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $230.74 · Expires 2036-06-02 | Direct | 4,036 |
Reported balance
After 2026-06-02 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-02 · Grant · Acquired 4,036 · Balance 4,036 F4: This option becomes exercisable as follows: 1,009 on June 2, 2027, 1,009 on June 2, 2028, 1,009 on June 4, 2029 and 1,009 on June 3, 2030. |
| Ordinary SharesSEC Table I · non-derivative | IndirectSee Footnote Below | 255 |
Reported balance
Holding disclosure · report date 2026-06-02 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 255 F3: Units representing 255 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029.
F2: 329 shares were withheld from the 1,128 restricted shares that vested on June 2, 2026. These 329 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.
F3: Units representing 255 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of May 29, 2026.
F4: This option becomes exercisable as follows: 1,009 on June 2, 2027, 1,009 on June 2, 2028, 1,009 on June 4, 2029 and 1,009 on June 3, 2030.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 4, 2026 20:34 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 4,036 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040845 · wk-form4_1780605257.xml · derivative · entry 4 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,036 Underlying: Ordinary Shares · 4,036 shares Expires 2036-06-02 F4 · derivative.exercise_date: This option becomes exercisable as follows: 1,009 on June 2, 2027, 1,009 on June 2, 2028, 1,009 on June 4, 2029 and 1,009 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:34 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 329 | $209.76 | $69,011.04 |
DisclosureSEC source: 0001628280-26-040845 · wk-form4_1780605257.xml · nonDerivative · entry 2 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,656 F2 · shares: 329 shares were withheld from the 1,128 restricted shares that vested on June 2, 2026. These 329 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:34 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040845 · wk-form4_1780605257.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,985 F1 · balance_after: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:41 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040443 · wk-form4_1780519289.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,830 F1 · shares: 198 shares were withheld from the 660 restricted shares that vested on June 1, 2026. These 198 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 3,090 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:32 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 798 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-000929 · wk-form4_1767735146.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,028 F1 · balance_after: As of January 2, 2026, 3,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.